ReportWire

Tag: synd

  • Tanking Biotech Stocks Will Mean a Big Year for Deals. Who Could Benefit.

    Tanking Biotech Stocks Will Mean a Big Year for Deals. Who Could Benefit.

    [ad_1]

    Nearly two years after biotechnology stocks began to tumble, executives at small and midsize companies in the space are finally accepting that share prices aren’t bouncing back anytime soon.

    With reality setting in, it’s a buyer’s market for companies looking for acquisitions and partnerships, according to many of the pharmaceutical and medical technology executives who gathered at this year’s


    J.P. Morgan


    healthcare investor conference, which wrapped up in San Francisco on Thursday.

    [ad_2]

    Source link

  • Too Much Government Debt Could Become a Big Problem for the Stock Market

    Too Much Government Debt Could Become a Big Problem for the Stock Market

    [ad_1]

    It’s always fun until the bill comes due—and the bill always comes due. In fact, it’s coming due right about now.

    On Friday, Treasury Secretary Janet Yellen warned Congress that the U.S. would hit its debt ceiling this coming Thursday, earlier than many had expected. That doesn’t mean the government will be forced to stop paying its bills then—Yellen believes that the Treasury has enough cash and other ways to raise money to last it until early June—but it does mean that an issue that was still purely theoretical has become far more pressing as the X date approaches.

    [ad_2]

    Source link

  • Delta Beats Profit Estimates. Why the Stock Is Falling.

    Delta Beats Profit Estimates. Why the Stock Is Falling.

    [ad_1]



    Delta Air Lines


    beat earnings estimates in the fourth quarter as air travel demand remained strong but the stock fell in early trading Friday as the carrier’s first quarter guidance disappointed.

    The airline (ticker: DAL) reported adjusted earnings per share of $1.48 in the fourth quarter, and revenue of $12.3 billion, an 8% increase on the same period in 2019.

    [ad_2]

    Source link

  • Ford Stock Is on Fire. The Reason Isn’t What You’d Expect.

    Ford Stock Is on Fire. The Reason Isn’t What You’d Expect.

    [ad_1]

    The outlook for the car market in 2023 is uncertain, but that isn’t stopping investors from piling into


    Ford Motor


    shares.



    Ford


    (ticker: F) stock is up 23 cents, or 1.9%, at $13.48 in midday trading Thursday. The


    S&P 500


    and


    Dow Jones Industrial Average


    are up about 0.9% and 0.7%, respectively.

    [ad_2]

    Source link

  • Eurozone Unemployment Rate Remained at Record Low in November Despite Slowing Economy

    Eurozone Unemployment Rate Remained at Record Low in November Despite Slowing Economy

    [ad_1]

    By Xavier Fontdegloria

    The eurozone jobless rate was stable in November at its record low, highlighting resilience in the labor market despite slowing economic growth.

    The eurozone unemployment rate stood at 6.5% in November, unchanged from October, data from the European Union’s statistics agency Eurostat showed Monday. This is the lowest level of the historical series, which dates back to 1998.

    The reading is in line with economists’ forecasts in a poll by The Wall Street Journal.

    The number of unemployed people was 10.97 million in November, also broadly unchanged from October, the statistics agency said.

    Eurozone unemployment is expected to increase slightly in the first half of 2023 as the economy falls into recession, economists say. The jobless rate is expected to increase to 7.0% in mid-2023, according to a consensus provided by FactSet.

    Write to Xavier Fontdegloria at xavier.fontdegloria@wsj.com

    [ad_2]

    Source link

  • AstraZeneca PLC Will Buy CinCor for Cardiorenal Asset

    AstraZeneca PLC Will Buy CinCor for Cardiorenal Asset

    [ad_1]

    By Joe Hoppe

    AstraZeneca PLC said Monday that it has agreed to buy CinCor Pharma, Inc., acquiring global rights to the latter’s baxdrostat cardiorenal drug for an upfront transaction value of around $1.3 billion.

    The Anglo-Swedish pharma giant said that it will initiate a tender offer to acquire all of U.S.-listed clinical-stage biopharmaceutical company CinCor’s outstanding shares, for a price of $26 a share in cash at the closing of the deal, along with a non-tradable contingent value right of $10 a share in cash payable upon a specified regulatory submission of a baxdrostat product. The deal is expected to close in the first quarter.

    The upfront cash portion of the acquisition represents a 121% premium to CinCor’s closing market price on Jan. 6 of $11.78.

    The combined upfront and maximum potential contingent value payments represent a transaction value of around $1.8 billion.

    AstraZeneca said the acquisition will bolster its cardiorenal pipeline by adding baxdrostat, an inhibitor for blood pressure lowering in treatment-resistant hypertension.

    Write to Joe Hoppe at joseph.hoppe@wsj.com

    [ad_2]

    Source link

  • Jack Ma Cedes Control of Fintech Giant Ant Group

    Jack Ma Cedes Control of Fintech Giant Ant Group

    [ad_1]

    Jack Ma Cedes Control of Fintech Giant Ant Group

    [ad_2]

    Source link

  • Eurozone Inflation Sharply Slowed in December as Energy Prices Dropped

    Eurozone Inflation Sharply Slowed in December as Energy Prices Dropped

    [ad_1]

    By Xavier Fontdegloria

    Eurozone inflation eased by more than expected in December, reaching a four-month low, driven by moderating energy prices and action from governments to cushion households from rising utility bills.

    Consumer prices rose 9.2% on year in December, easing from a 10.1% increase in November and the lowest level since August, according to preliminary data from the European Union’s statistics agency Eurostat published Friday.

    The reading is below economists’ forecasts, who expected a 9.7% inflation rate in a poll by The Wall Street Journal.

    Inflation reached 10.6% in October, the highest level since records began in 1997, but has fallen since then driven by lower energy prices amid unusually warm weather in most of Europe. Moreover, some countries such as Germany implemented in December a one-off subsidy for household energy bills, pushing down headline inflation further.

    Energy prices in the eurozone moderated significantly in December, but were still 25.7% higher than the same month a year earlier, compared with a 34.9% increase in November. Food, alcohol and tobacco price inflation accelerated slightly to 13.8% from 13.6% a month earlier.

    However, there were signs that price pressures persisted at year-end. The core inflation rate–which strips out the more volatile categories of food and energy–rose to 5.2% from 5.0% in November.

    The European Central Bank raised interest rates at an unprecedented pace in 2022 in order to tame high inflation. Despite the recent slowdown in inflation, the bank said it expects to increase rates further in 2023 to ensure inflation falls back to its 2% medium-term target.

    Write to Xavier Fontdegloria at xavier.fontdegloria@wsj.com

    [ad_2]

    Source link

  • EV Startup Rivian Missed 2022 Production Target

    EV Startup Rivian Missed 2022 Production Target

    [ad_1]

    EV Startup Rivian Missed 2022 Production Target

    [ad_2]

    Source link

  • Contraction in U.S. Factory Sector Deepened in December — S&P Global

    Contraction in U.S. Factory Sector Deepened in December — S&P Global

    [ad_1]

    By Xavier Fontdegloria

    The U.S. manufacturing sector contracted in December at the steepest pace since the onset of the Covid-19 pandemic as demand remained subdued and production weakened, data from a purchasing managers survey showed Tuesday.

    The S&P Global U.S. manufacturing PMI decreased to 46.2 in December from 47.7 in November, posting the lowest reading since the initial Covid-19 lockdown period in May 2020 and unchanged from the preliminary reading.

    The index suggests factory activity shrank in December for a second consecutive month as any reading below 50.0 indicates contraction.

    The contraction in activity was led by faster downturns in output and new orders, and companies attributed weak client demand to increasing economic uncertainty and high inflation, the report said.

    “The manufacturing sector posted a weak performance as 2022 was brought to a close,” said Sian Jones, senior economist at S&P Global.

    Concerns about the economic outlook turned firms more cautious in terms of hiring, and December saw job creation increasing only slightly and largely linked to skilled hires, she said.

    Weaker activity at year-end led to easing price pressures, according to the survey. Both input and output inflation moderated at factory gates, and supply-chain bottlenecks were less apparent than earlier in the year.

    “Slower upticks in inflation signal the impact of Federal Reserve policy on prices, but growing uncertainty and tumbling demand suggest challenges for manufacturers will roll over into the new year,” Ms. Jones said.

    Write to Xavier Fontdegloria at xavier.fontdegloria@wsj.com

    [ad_2]

    Source link

  • Tesla Sets a Delivery Record.  Wall Street Will Still Cringe.

    Tesla Sets a Delivery Record. Wall Street Will Still Cringe.

    [ad_1]



    Tesla


    stock had a rocky 2022, and


    Tesla


    investors hoped that fourth-quarter EV deliveries would help get 2023 started with a bang. It looks like they’ll be disappointed, as the actual numbers fell short of expectations, sending Tesla stock lower in premarket trading Tuesday.

    On Monday, Tesla (ticker: TSLA) reported fourth-quarter deliveries of 405,278. It’s a record result, but it missed Wall Street expectations.

    [ad_2]

    Source link

  • The Top Luxury Home Builder Is a Buy for 2023

    The Top Luxury Home Builder Is a Buy for 2023

    [ad_1]

    This article is an excerpt from “Here Are Barron’s 10 Top Stocks for the New Year,” published on Dec. 16, 2022. To see the full list, click here

    With home builder


    Toll Brothers


    ‘ stock down 30% this year, it might look like the roof is caving in. But that’s probably not the case. Yes, mortgage rates have doubled, but Toll (ticker: TOL), the top luxury home builder, is more insulated than its peers, due to the affluent buyers of its homes, which sell for an average of about $1 million. About 20% of Toll buyers pay cash, and many are selling homes for a lot more than they paid for them.

    [ad_2]

    Source link

  • Trump’s Tax Law Echoed Through His Finances During White House Years

    Trump’s Tax Law Echoed Through His Finances During White House Years

    [ad_1]

    Returns released by House show provisions of tax code that were used

    [ad_2]
    Source link

  • The Dow Buried the Nasdaq. Now, What Happens Next.

    The Dow Buried the Nasdaq. Now, What Happens Next.

    [ad_1]

    Y2K is back in a big way in the fashion world, but history isn’t just repeating itself on the runway. The stock market appears to be nostalgic for the early 2000s, as it is once again turning its back on tech.

    There were few places for investors to hide in this year’s bloodbath, but those exposed to the tech-heavy


    Nasdaq Composite


    index undoubtedly had it the worst. Through the close Friday, the last trading day of the year, the Nasdaq had plummeted 33.1% in 2022, falling 8.7% in the past month alone.

    [ad_2]

    Source link

  • AMD Stock Should Benefit From Next-Generation Computer Chips

    AMD Stock Should Benefit From Next-Generation Computer Chips

    [ad_1]

    These reports, excerpted and edited by Barron’s, were issued recently by investment and research firms. The reports are a sampling of analysts’ thinking; they should not be considered the views or recommendations of Barron’s. Some of the reports’ issuers have provided, or hope to provide, investment-banking or other services to the companies being analyzed.

    Advanced Micro Devices AMD-Nasdaq

    Buy (four stars out of five) • Price $64.52 on Dec. 23

    by CFRA

    Our Buy recommendation reflects our expectation for significant share gains on the central-processing-unit data-center side from the ramp-up of AMD’s next-generation EPYC processor, greater momentum for AMD’s graphics processing units, and our expectation for balance sheet improvement.

    [ad_2]

    Source link

  • Sam Bankman-Fried Likely to Plead Not Guilty to Fraud Charges

    Sam Bankman-Fried Likely to Plead Not Guilty to Fraud Charges

    [ad_1]

    FTX founder Sam Bankman-Fried.


    David Dee Delgado/Getty Images

    FTX founder Sam Bankman-Fried is likely to plead not guilty to fraud and other charges at his arraignment next week, according to people familiar with the matter.

    The U.S. attorney’s office for the Southern District of New York earlier this month charged Mr. Bankman-Fried with engaging in criminal conduct that contributed to the cryptocurrency exchange’s collapse, alleging that he oversaw one of the biggest financial frauds in American history. Mr. Bankman-Fried is likely to appear in person in New York to enter his plea on Jan. 3, one of the people said.

    Before his arrest, Mr. Bankman-Fried blamed the loss of customer funds on sloppy record-keeping and a bank-account issue that allowed Alameda Research, an affiliated trading firm, to cover large losses with money destined for FTX. His not guilty plea was widely expected.

    Mr. Bankman-Fried stands at odds with his associates—Caroline Ellison, the former chief executive of Alameda Research, and Gary Wang, FTX’s former chief technology officer—who both pleaded guilty to criminal offenses similar to those Mr. Bankman-Fried was charged with. Both are cooperating with federal investigators.

    The collapse of FTX and its sister trading firm Alameda have rattled the nascent world of crypto. Prosecutors allege that Mr. Bankman-Fried took billions of dollars of FTX.com customer money to pay the expenses and debts of his trading firm Alameda Research. Both companies filed for bankruptcy last month. Individual traders who entrusted FTX with their crypto are likely facing lengthy bankruptcy proceedings before they have a chance at seeing any of their funds back.

    Read the rest of this article in The Wall Street Journal.

    Write to editors@barrons.com

    [ad_2]

    Source link

  • China Regulator Says Futu, Up Fintech Violated Laws

    China Regulator Says Futu, Up Fintech Violated Laws

    [ad_1]

    China Regulator Says Futu, Up Fintech Violated Laws

    [ad_2]

    Source link

  • China Approves Merck’s Molnupiravir for Emergency Use, Regulator Says

    China Approves Merck’s Molnupiravir for Emergency Use, Regulator Says

    [ad_1]

    China’s top drug regulator said Friday that it approved Merck & Co.’s Molnupiravir for emergency use on Thursday, as the country grapples with waves of infections after Beijing abruptly reversed its stringent Covid-19 restrictions earlier this month.

    The National Medical Products Administration said it is requiring the approval holder to continue relevant research, complete conditional requirements and submit follow-up research results in a timely manner, according to a statement posted on its website Friday.

    Write to Singapore Editors at singaporeeditors@dowjones.com

    Corrections & Amplifications

    This item was corrected at 0856 GMT to reflect China’s top drug regulator said it approved Merck & Co.’s Molnupiravir for emergency use on Thursday. The original version incorrectly said the approval came on Wednesday in the first paragraph.

    [ad_2]

    Source link

  • Southwest, NIO, AMC, Tesla, and More Stock Market Movers Tuesday

    Southwest, NIO, AMC, Tesla, and More Stock Market Movers Tuesday

    [ad_1]


    • Order Reprints

    • Print Article


    [ad_2]

    Source link

  • Cheap? Maybe. But These Stocks Have Been Dead Money for Decades

    Cheap? Maybe. But These Stocks Have Been Dead Money for Decades

    [ad_1]

    Cheesecake Factory appears to be “running the same play,” wrote J.P. Morgan analyst John Ivankoe in a recent restaurant industry outlook. I don’t think he meant it as a compliment—the stock, he noted, trades where it did in 2004, adjusted for splits.

    Why the long stall-out? My first thought was that maybe hitting the mall for a hypercaloric sit-down meal off a menu the size of a Gutenberg Bible has fallen out of favor over the years. But no: Sales have bounced back and then some from the Covid pandemic, with plenty of takeout business and dessert orders. The average


    Cheesecake Factory


    (ticker: CAKE) restaurant does more than $10 million in yearly sales, or twice as much as an Olive Garden.

    [ad_2]

    Source link